1 |
0.9% w/v isotonic sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
050 1件: 50 💬 |
2 |
10% nifedipine cream |
Nifedipine |
1件: D00437 D00437 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
050 1件: 50 💬 |
3 |
3 mpdn pulse + pdn |
- |
- |
- |
- |
050 1件: 50 💬 |
4 |
3 mpdn pulse + pdn + csa |
- |
- |
- |
- |
050 1件: 50 💬 |
5 |
3 mpdn pulse + pdn + mtx |
- |
- |
- |
- |
050 1件: 50 💬 |
6 |
35mg |
- |
- |
- |
- |
050 1件: 50 💬 |
7 |
44/154/85-c |
- |
- |
- |
- |
050 1件: 50 💬 |
8 |
44/196/81-c |
- |
- |
- |
- |
050 1件: 50 💬 |
9 |
5% sildenafil cream |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
050 1件: 50 💬 |
10 |
56/104/75-c |
- |
- |
- |
- |
050 1件: 50 💬 |
11 |
5mg |
- |
- |
- |
- |
050 1件: 50 💬 |
12 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
13 |
Abatacept active treatment |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
050 1件: 50 💬 |
14 |
Abatacept delayed-onset treatment |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
050 1件: 50 💬 |
15 |
Abatacept subcutaneous |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
050 1件: 50 💬 |
16 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
17 |
Acthar gel |
- |
- |
- |
- |
013 6件: 13, 46, 49, 50, 84, 222 💬 |
18 |
Adrenocorticotropic hormone |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 3件: 13, 50, 84 💬 |
19 |
Adrenocorticotropic hormone gel |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
050 1件: 50 💬 |
20 |
Ajulemic acid |
Ajulemic acid |
1件: D11312 D11312 💬 |
CNR2 1件: CNR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
050 3件: 50, 51, 299 💬 |
21 |
Alendronate |
Alendronic acid |
2件: D00939 D00939, D07119 D07119 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 7件: 19, 41, 46, 50, 271, 274, 299 💬 |
22 |
Alendronate versus alfacalcidol (1-alpha oh vitamin d) |
Alendronic acid |
3件: D00939 D00939, D01518 D01518, D07119 D07119 💬 |
FDPS 2件: FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 8件: Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
041 3件: 41, 46, 50 💬 |
23 |
Alfacalcidol |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
24 |
Alfacalcidol 2 micrograms/ml |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
050 1件: 50 💬 |
25 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
26 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 5件: 46, 49, 50, 51, 53 💬 |
27 |
Apremilast |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271 💬 |
28 |
Apremilast 30mg |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
050 1件: 50 💬 |
29 |
Baf312 |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
30 |
Baf312 0,5 mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
31 |
Baf312 0.25 mg |
- |
- |
- |
- |
050 1件: 50 💬 |
32 |
Baf312 0.25 mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
33 |
Baf312 0.25mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
34 |
Baf312 0.5 mg |
- |
- |
- |
- |
050 1件: 50 💬 |
35 |
Baf312 0.50 mg |
- |
- |
- |
- |
050 1件: 50 💬 |
36 |
Baf312 1 mg |
- |
- |
- |
- |
050 1件: 50 💬 |
37 |
Baf312 1 mg tablet |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
38 |
Baf312 1mg |
- |
- |
- |
- |
050 1件: 50 💬 |
39 |
Baf312 1mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
40 |
Baf312 2 mg |
- |
- |
- |
- |
050 1件: 50 💬 |
41 |
Baf312 2 mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
42 |
Baf312 2mg |
- |
- |
- |
- |
050 1件: 50 💬 |
43 |
Baf312 4mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
44 |
Baf312 5 mg tablet |
- |
- |
- |
- |
050 1件: 50 💬 |
45 |
Baf312 hemifumarate |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
46 |
Baf312x |
- |
- |
- |
- |
050 1件: 50 💬 |
47 |
Baricitinib |
Baricitinib |
1件: D10308 D10308 💬 |
JAK1 2件: JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
48 |
Basiliximab |
Basiliximab |
1件: D03058 D03058 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 6件: 2 , 50, 65, 97, 222, 228 💬 |
49 |
Calcineurin inhibitors |
- |
- |
- |
- |
050 1件: 50 💬 |
50 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
51 |
Carbon dioxide |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 3件: 50, 51, 97 💬 |
52 |
Cervarix |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
53 |
Cervarix suspensie voor injectie |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
54 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
55 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
56 |
Creapure |
- |
- |
- |
- |
050 1件: 50 💬 |
57 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
58 |
Csa |
- |
- |
- |
- |
019 8件: 19, 49, 50, 53, 60, 63, 222, 228 💬 |
59 |
Cya |
- |
- |
- |
- |
050 2件: 50, 222 💬 |
60 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
61 |
Cyclophosphamide injection 1g |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
050 3件: 50, 51, 52 💬 |
62 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
63 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
64 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
65 |
Denosumab |
Denosumab |
1件: D03684 D03684 💬 |
TNFSF11 1件: TNFSF11 💬 |
Breast cancer 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 7件: 46, 50, 93, 95, 96, 274, 299 💬 |
66 |
Device: fractionated carbon dioxide (fco2) laser |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 1件: 50 💬 |
67 |
Drops |
- |
- |
- |
- |
050 1件: 50 💬 |
68 |
Emea/h/c/000701 |
- |
- |
- |
- |
050 1件: 50 💬 |
69 |
Etanercept |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 14件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
70 |
Gamma globulin |
- |
- |
- |
- |
015 2件: 15, 50 💬 |
71 |
Gb-0998 |
- |
- |
- |
- |
050 1件: 50 💬 |
72 |
Gevokizumab |
Gevokizumab |
1件: D09911 D09911 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
041 4件: 41, 50, 56, 269 💬 |
73 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
74 |
Glucose tablet |
Dextrose, unspecified form |
- |
- |
- |
050 1件: 50 💬 |
75 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
76 |
Grapefruit |
Grapefruit |
- |
- |
- |
006 5件: 6 , 46, 50, 83, 97 💬 |
77 |
H.p. acthar gel |
- |
- |
- |
- |
046 5件: 46, 49, 50, 84, 222 💬 |
78 |
H5g1.1-mab |
- |
- |
- |
- |
013 3件: 13, 50, 62 💬 |
79 |
Hbvaxpro |
- |
- |
- |
- |
046 2件: 46, 50 💬 |
80 |
Hizentra |
- |
- |
- |
- |
014 4件: 14, 50, 51, 65 💬 |
81 |
Human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
014 4件: 14, 50, 63, 65 💬 |
82 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
83 |
Human normal immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
050 2件: 50, 65 💬 |
84 |
Human normal immunoglogulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
050 1件: 50 💬 |
85 |
Ifn-k |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
86 |
Ifn-kinoid |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
87 |
Ifn-kinoid drug substance |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
88 |
Ifna-kinoid |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
89 |
Ig vena |
- |
- |
- |
- |
050 2件: 50, 63 💬 |
90 |
Ig vena (10g/200ml) |
- |
- |
- |
- |
050 1件: 50 💬 |
91 |
Igpro20 |
- |
- |
- |
- |
014 4件: 14, 50, 51, 65 💬 |
92 |
Igvena*fl 200ml 10g+set |
- |
- |
- |
- |
014 2件: 14, 50 💬 |
93 |
Immunoglobulin (hizentra) |
- |
- |
- |
- |
050 1件: 50 💬 |
94 |
Immunoglobulin g |
- |
- |
- |
- |
011 7件: 11, 13, 14, 49, 50, 63, 65 💬 |
95 |
Immunosuppressive agents |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
96 |
Imo-8400 |
- |
- |
- |
- |
050 1件: 50 💬 |
97 |
Imo-8400 dose group 1 |
- |
- |
- |
- |
050 1件: 50 💬 |
98 |
Imo-8400 dose group 2 |
- |
- |
- |
- |
050 1件: 50 💬 |
99 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
100 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
101 |
Influvac |
- |
- |
- |
- |
046 3件: 46, 49, 50 💬 |
102 |
Isotone kochsalz-lösung 0,9 % braun infusionslösung |
- |
- |
- |
- |
050 1件: 50 💬 |
103 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬 |
104 |
Jbt-101 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 299 💬 |
105 |
Kzr-616 |
KZR-616 |
- |
- |
- |
049 3件: 49, 50, 61 💬 |
106 |
Kzr-616 maleate |
KZR-616 |
- |
- |
- |
050 1件: 50 💬 |
107 |
L0133 |
- |
- |
- |
- |
050 1件: 50 💬 |
108 |
Lenabasum |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
109 |
Lenabasum 20 mg |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
110 |
Lenabasum 5 mg |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
111 |
Lipid-lowering agents (artovastatin) |
- |
- |
- |
- |
050 1件: 50 💬 |
112 |
Ly3009104 |
- |
- |
- |
- |
046 6件: 46, 49, 50, 93, 107, 325 💬 |
113 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
114 |
Medi-545 |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
115 |
Medi7734 |
- |
- |
- |
- |
050 1件: 50 💬 |
116 |
Methimazole |
Methimazole |
1件: D00401 D00401 💬 |
TPO 1件: TPO 💬 |
Autoimmune thyroid disease 4件: Autoimmune thyroid disease, Metabolic pathways, Thyroid hormone synthesis, Tyrosine metabolism |
050 1件: 50 💬 |
117 |
Methotrexat |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 4件: 13, 46, 50, 96 💬 |
118 |
Methotrexat lachema 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
119 |
Methotrexat lachema 2,5mg tbl. |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
120 |
Methotrexat lachema 5 inj. sol |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
121 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
122 |
Methotrexate lachema 5inj. sol |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
123 |
Methotrexate wyeth 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
124 |
Methotrexate wyeth 2,5mg tbl. |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
125 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
126 |
Methylprednisolone sodium succinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 6件: 13, 46, 49, 50, 51, 211 💬 |
127 |
Methylprednisoloni natrii succinas |
- |
- |
- |
- |
050 1件: 50 💬 |
128 |
Metoject 10 mg/ml |
- |
- |
- |
- |
050 1件: 50 💬 |
129 |
Metotrexat |
- |
- |
- |
- |
050 2件: 50, 96 💬 |
130 |
Metotrexate |
- |
- |
- |
- |
050 1件: 50 💬 |
131 |
Mmf |
- |
- |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
132 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
133 |
Nifedipine |
Nifedipine |
1件: D00437 D00437 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
050 2件: 50, 81 💬 |
134 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
135 |
Octagam 10% |
- |
- |
- |
- |
050 3件: 50, 63, 65 💬 |
136 |
Octanorm |
- |
- |
- |
- |
050 2件: 50, 65 💬 |
137 |
Octanorm 16.5% |
- |
- |
- |
- |
050 2件: 50, 65 💬 |
138 |
One alpha |
- |
- |
- |
- |
050 1件: 50 💬 |
139 |
One alpha drops |
- |
- |
- |
- |
050 1件: 50 💬 |
140 |
One-alpha |
- |
- |
- |
- |
050 1件: 50 💬 |
141 |
One-alpha drops |
- |
- |
- |
- |
050 1件: 50 💬 |
142 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
143 |
Orencia (trade name) |
- |
- |
- |
- |
050 1件: 50 💬 |
144 |
Other: isa 51 |
- |
- |
- |
- |
050 1件: 50 💬 |
145 |
Pf-06823859 high |
- |
- |
- |
- |
050 1件: 50 💬 |
146 |
Pf-06823859 low |
- |
- |
- |
- |
050 1件: 50 💬 |
147 |
Pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
148 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
149 |
Placebo iv |
- |
- |
- |
- |
050 1件: 50 💬 |
150 |
Placebo sc |
- |
- |
- |
- |
050 1件: 50 💬 |
151 |
Pneumovax 23 |
- |
- |
- |
- |
046 2件: 46, 50 💬 |
152 |
Prednisolon |
- |
- |
- |
- |
046 6件: 46, 50, 51, 66, 96, 97 💬 |
153 |
Prednisolon pfizer |
- |
- |
- |
- |
050 1件: 50 💬 |
154 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
155 |
Prednison 5, 20 léciva por. tablet nob |
- |
- |
- |
- |
050 1件: 50 💬 |
156 |
Prednison 5, 20 léciva por. tablet nob. |
- |
- |
- |
- |
050 1件: 50 💬 |
157 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
158 |
Resunab, ajulemic acid, anabasum |
Ajulemic acid |
1件: D11312 D11312 💬 |
CNR2 1件: CNR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
050 3件: 50, 51, 299 💬 |
159 |
Risedronate |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 6件: 46, 50, 66, 96, 113, 274 💬 |
160 |
Risedronate sodium |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
050 3件: 50, 113, 274 💬 |
161 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
162 |
S78989 |
- |
- |
- |
- |
041 3件: 41, 50, 56 💬 |
163 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
164 |
Siponimid |
- |
- |
- |
- |
050 1件: 50 💬 |
165 |
Siponimod |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
166 |
Siponimod 0.25 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
167 |
Siponimod 0.5 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
168 |
Siponimod 1 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
169 |
Siponimod 2 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
170 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
171 |
Sodium thiosulfate |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
172 |
Sodium thiosulfate 10% |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
173 |
Sodium thiosulfate pentahydrate |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
174 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
175 |
Solu-medrol inj. pso lqf 40mg |
- |
- |
- |
- |
050 1件: 50 💬 |
176 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
177 |
Sts |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
178 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
179 |
Tocilizumab |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
180 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
181 |
Tofacitinib 5 mg [xeljanz] |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 50 💬 |
182 |
Treatment defined only by active substance |
- |
- |
- |
- |
050 1件: 50 💬 |
183 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
184 |
Ustekinumab 6 mg/kg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
050 1件: 50 💬 |
185 |
Ustekinumab 90 mg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 4件: 49, 50, 93, 96 💬 |
186 |
Vib7734 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 53 💬 |
187 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
188 |
Xoma 052 |
- |
- |
- |
- |
041 5件: 41, 46, 50, 56, 106 💬 |
189 |
Yellow fever vaccine |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |
190 |
Yellow fever vaccine (17d) |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |